These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23106932)

  • 21. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia.
    Smith MJ; Horan WP; Karpouzian TM; Abram SV; Cobia DJ; Csernansky JG
    Schizophr Res; 2012 May; 137(1-3):196-202. PubMed ID: 22321668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cognitive remediation on neurocognitive functions and psychiatric symptoms in schizophrenia inpatients.
    Gharaeipour M; Scott BJ
    Schizophr Res; 2012 Dec; 142(1-3):165-70. PubMed ID: 23102691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
    Meiron O; Hermesh H; Katz N; Weizman A
    Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
    Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
    Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
    Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma total antioxidant status and cognitive impairments in schizophrenia.
    Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
    Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.
    Yolken RH; Torrey EF; Lieberman JA; Yang S; Dickerson FB
    Schizophr Res; 2011 May; 128(1-3):61-5. PubMed ID: 21353483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M; Anselmetti S; Pirovano A; Ermoli E; Marino E; Bramanti P; Smeraldi E; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):81-5. PubMed ID: 19818823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.
    Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    J Psychiatr Res; 2012 Jun; 46(6):757-61. PubMed ID: 22464338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preserved cognitive function is associated with suicidal ideation and single suicide attempts in schizophrenia.
    Delaney C; McGrane J; Cummings E; Morris DW; Tropea D; Gill M; Corvin A; Donohoe G
    Schizophr Res; 2012 Sep; 140(1-3):232-6. PubMed ID: 22796150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Less cognitive and neurological deficits in schizophrenia patients carrying risk variant in ZNF804A.
    Van Den Bossche MJ; Docx L; Morrens M; Cammaerts S; Strazisar M; Bervoets C; Smolders S; Depreeuw V; Lenaerts AS; De Rijk P; Del-Favero J; Sabbe BG
    Neuropsychobiology; 2012; 66(3):158-66. PubMed ID: 22948380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis.
    Potvin S; Joyal CC; Pelletier J; Stip E
    Schizophr Res; 2008 Mar; 100(1-3):242-51. PubMed ID: 17614260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive functioning and age at onset in non-affective psychotic disorder.
    van der Werf M; Köhler S; Verkaaik M; Verhey F; van Os J;
    Acta Psychiatr Scand; 2012 Oct; 126(4):274-81. PubMed ID: 22582732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.
    Boyer L; Richieri R; Dassa D; Boucekine M; Fernandez J; Vaillant F; Padovani R; Auquier P; Lancon C
    Psychiatry Res; 2013 Dec; 210(2):381-6. PubMed ID: 23850204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients.
    Hori H; Yoshimura R; Katsuki A; Sugita AI; Atake K; Nakamura J
    J Psychiatr Res; 2013 Dec; 47(12):1843-8. PubMed ID: 24054464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study.
    Galderisi S; Davidson M; Kahn RS; Mucci A; Boter H; Gheorghe MD; Rybakowski JK; Libiger J; Dollfus S; López-Ibor JJ; Peuskens J; Hranov LG; Fleischhacker WW;
    Schizophr Res; 2009 Dec; 115(2-3):104-14. PubMed ID: 19822407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool.
    Fervaha G; Agid O; Foussias G; Remington G
    J Psychiatr Res; 2014 May; 52():50-6. PubMed ID: 24507885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.